What physicians need to implement safer opioid prescribing: A qualitative study.


Journal

Journal of opioid management
ISSN: 1551-7489
Titre abrégé: J Opioid Manag
Pays: United States
ID NLM: 101234523

Informations de publication

Date de publication:
Historique:
entrez: 19 12 2019
pubmed: 19 12 2019
medline: 8 1 2020
Statut: ppublish

Résumé

In response to the US opioid epidemic, the Centers for Disease Control and Prevention issued a guideline (CDCG) for prescribing opioids for chronic pain. Successful implementation of the CDCG requires identification of the information, skills, and support physicians need to carry out its recommendations. However, such data are currently lacking. The authors performed one-on-one interviews with nine practicing physicians regarding their needs and perspectives for successful CDCG implementation, including the perceived barriers, focusing on communication strategies. Interviews were audio recorded, transcribed, and a thematic qualitative analysis was performed. Three major themes were identified: communication, knowledge, and information technology (IT). Physicians reported that open communication with patients about opioids was difficult and burdensome, but essential; they shared their communication strategies. Knowledge gaps included patient-specific topics (eg, availability of/insurance coverage for non-opioid treatments) and more general areas (eg, opioid dosing/equivalencies, prescribing naloxone). Finally, physicians discussed the importance of innovation in IT, focusing on the electronic medical record for decision support and to allow safer opioid prescribing within the time constraints of clinical practice. These qualitative data document practical issues that should be considered in the development of implementation plans for safer opioid prescribing practices. Specifically, healthcare systems may need to provide opioid-relevant communication strategies and training, education on key topics such as naloxone prescribing, resources for referrals to appropriate nonpharmacologic treatments, and innovative IT solutions. Future research is needed to establish that such measures will be effective in producing better outcomes for patients on opioids for chronic pain.

Identifiants

pubmed: 31850509
pii: jom.2019.0538
doi: 10.5055/jom.2019.0538
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Naloxone 36B82AMQ7N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-485

Déclaration de conflit d'intérêts

Sponsored Review

Auteurs

Allison Navis (A)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.

Mary Catherine George (MC)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.

Maya Scherer (M)

Center for Evaluations and Applied Research, New York Academy of Medicine, New York, New York.

Linda Weiss (L)

Center for Evaluations and Applied Research, New York Academy of Medicine, New York, New York.

Yosuke Chikamoto (Y)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.

Jessica Robinson-Papp (J)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH